Evoke Pharma, Inc.
Evoke Pharma, Inc. (EVOK) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
evok · stock forecast · 12 analysts (3M) · FMP
Analyst Rating & Consensus
Based on 12 Wall Street analysts in the past 3 months
Buy
12 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$18.00
Consensus
$18.00
+63.6% upside
Low
$18.00
Median: $18 · Last Close: $11.00
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Short-term price predictions will be available once the prediction engine is ready.
Long-Term Stock Price Prediction
Long-term price predictions will be available once the prediction engine is ready.
Stock Forecast Based on Technical Analysis
Technical analysis will be available once the prediction engine is ready.
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|
Wall Street analysts have recently issued updated ratings on Evoke Pharma, Inc. (EVOK) stock. Of the recent 0 rating actions, 0 were upgrades and 0 were downgrades. 12 analysts currently cover EVOK.
Analyst Recommendation Trends
EVOK analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
—
Revenue Next Year
—
EPS This Year
—
EPS Next Year
—
EPS ForecastReported vs Estimated
Analysts forecast EVOK EPS of $— for the current fiscal year, based on estimates from 0 analysts. The EVOK revenue forecast is — for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The EVOK stock forecast is supported by two independent data sources: analyst consensus ratings from 12 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus EVOK price target is $18.00 (+63.6% upside), with an analyst consensus of Buy.
Evoke Pharma, Inc. trades on NASDAQ under the ticker EVOK. The EVOK stock outlook for 2027 is broadly positive, supported by a Buy consensus among 75% of covering analysts.
Frequently asked questions
EVOK forecast · 8 questionsAccording to 12 Wall Street analysts, the average 12-month EVOK price target is $18.00, with a high forecast of $18.00 and a low of $18.00. The median price target is shown in the chart above when available. This implies +63.6% potential upside from the current price of $11.00.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.